Cell Therapy Development News Today

Please raise their hand. The u. N. Security council gets tough on north korea. And the north responds likewise. Delegates at the United Nations have agreed to expand sanctions on north korea. The Security Council condemned a rocket launch there last month. Chinese delegates have long provided diplomatic protection for their north korean allies. But they approved the resolution and members adopted it unanimously. The statement criticizes the launch as a violation of previous resolutions. The Secu...

Please raise their hand. The u. N. Security council gets tough on north korea. And the north responds likewise. Delegates at the United Nations have agreed to expand sanctions on north korea. The Security Council condemned a rocket launch there last month. Chinese delegates have long provided diplomatic protection for their north korean allies. But they approved the resolution and members adopted it unanimously. The statement criticizes the launch as a violation of previous resolutions. The Secu...

/PRNewswire/ -- "Gene Synthesis: Technologies and Global Markets" is like a detailed look into how genes are made in labs and how this process impacts the...

Phase 1b DLBCL-001 study reinforces promising activity and combinability of golcadomide with R-CHOP in patients with previously untreated aggressive B-cell lymphoma Phase 1/2 CC-99282-NHL-001 study...

12.12.2023 - Bristol Myers Squibb (NYSE: BMY) announced the results of two early studies evaluating combinations of potential first-in-class CELMoD agent golcadomide in non-Hodgkin lymphomas. These data are being presented in separate posters (#4459, #4496, ... Seite 1

Dublin, Oct. 31, 2023 (GLOBE NEWSWIRE) -- The

In TRANSCEND FL, 97% of patients with relapsed or refractory follicular lymphoma treated with Breyanzi achieved a response, with 94% achieving a complete response, and 81.9% of responders in ongoing... | June 17, 2023

PRINCETON, N.J.--(BUSINESS WIRE)--Jun 17, 2023--

PRINCETON, N.J.--(BUSINESS WIRE)--Jun 17, 2023--

/PRNewswire/ -- - The COVID-19 pandemic has had a limited impact on the global breast cancer therapeutics market and reports see substantial growth now that it...